arXiv Machine Learning June 3, 2026 By Esmaeil Shakeri, Ronnie de Souza Santos, Behrouz Far

Fairness Definitions and Metrics in Deep Reinforcement Learning for Drug Discovery in Healthcare: A Rapid Evidence Review

Read the original on arXiv Machine Learning →

arXiv:2606. 02902v1 Announce Type: cross Abstract: Deep reinforcement learning (DRL) is increasingly applied to de novo molecular design, but choices in data, rewards, and evaluation can yield uneven performance across disease areas and chemotypes.

Summary generated by The Flow from the publisher's feed. The full article lives at arXiv Machine Learning.

arXiv Machine Learning

Jun 2

Genotype-Conditioned Molecular Generation via Evidence-Grounded Multi-Objective Latent Perturbation in Diffusion Models

arXiv:2606. 01461v1 Announce Type: new Abstract: Developing effective anticancer therapeutics remains challenging due to tumor heterogeneity and the absence of well-defined molecular targets across cancer subtypes.

By Brenda Nogueira, Gisela A. Gonzalez-Montiel, Nitesh V. Chawla, Nuno Moniz

llms agents diffusion

arXiv Machine Learning

6d ago

Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling

arXiv:2608. 11444v1 Announce Type: cross Abstract: Drug response prediction (DRP) models are an active area of research in pharmacogenomics, with growing potential to accelerate the identification of effective anticancer drugs.

By Vincent Lavelle, Yitan Zhu, Kaitlyn Marlor, Thomas Brettin, Rick Stevens

benchmarks

arXiv Machine Learning

Aug 4

Refine Drugs, Don't Complete Them: Uniform-Source Discrete Flows for Fragment-Based Drug Discovery

arXiv:2509. 26405v2 Announce Type: replace Abstract: We introduce InVirtuoGen, a discrete flow generative model for fragmented SMILES for de novo and fragment-constrained generation, and target-property/lead optimization of small molecules.

By Benno Kaech, Luis Wyss, Karsten Borgwardt, Gianvito Grasso

fine-tuning benchmarks

arXiv Machine Learning

Jul 22

Adopting Reinforcement Learning with Verifiable Rewards for Molecular Generation

arXiv:2607. 19044v1 Announce Type: new Abstract: Leveraging large language models (LLMs) for molecular generation has shown remarkable potential in chemical and drug design.

By Mingxuan Ouyang, Hao Lan, Wanyu Lin

llms reinforcement-learning fine-tuning benchmarks

arXiv AI

Jul 10

DrugGen 2: A disease-aware language model for enhancing drug discovery

arXiv:2607. 08404v1 Announce Type: cross Abstract: Current computational approaches for drug design typically focus on generating molecules conditioned on specific targets or general molecular properties, often neglecting the influence of disease context on target behavior and therapeutic outcomes.

By Ali Motahharynia, Mohammadreza Ghaffarzadeh-Esfahani, Mahsa Sheikholeslami, Navid Mazrouei, Matin Irajpour, Yousof Gheisari, Hajar Sirous

llms reinforcement-learning fine-tuning

arXiv AI

Jun 2

Fine-Tuning Diffusion Models for Molecular Generation via Reinforcement Learning and Fast Sampling

arXiv:2606. 01220v1 Announce Type: cross Abstract: Generating molecules that simultaneously satisfy drug-like properties and conform to the 3D structure of a target protein is a core challenge in structure-based drug design (SBDD).

By Guang Lin, Shikui Tu, Lei Xu

diffusion reinforcement-learning fine-tuning benchmarks data-engineering

Related stories

Genotype-Conditioned Molecular Generation via Evidence-Grounded Multi-Objective Latent Perturbation in Diffusion Models

Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling

Refine Drugs, Don't Complete Them: Uniform-Source Discrete Flows for Fragment-Based Drug Discovery

Adopting Reinforcement Learning with Verifiable Rewards for Molecular Generation

DrugGen 2: A disease-aware language model for enhancing drug discovery

Fine-Tuning Diffusion Models for Molecular Generation via Reinforcement Learning and Fast Sampling